AGENUS INC Basic Shares Outstanding (Weighted Average)
AGENUS INC (AGEN) reported Basic Shares Outstanding (Weighted Average) of 41.34 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-07
- AGENUS INC weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 41.34M shares, a 47.02% increase year-over-year.
- AGENUS INC weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 37.94M shares, a 55.06% increase year-over-year.
- AGENUS INC weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 34.38M shares, a 50.10% increase year-over-year.
- AGENUS INC weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 31.89M shares, a 47.96% increase year-over-year.
- AGENUS INC weighted average number of shares outstanding, basic for fiscal 2025 was 29.73M shares, a 38.47% increase from fiscal 2024.
- AGENUS INC weighted average number of shares outstanding, basic for fiscal 2024 was 21.47M shares, a 20.00% increase from fiscal 2023.
- AGENUS INC weighted average number of shares outstanding, basic for fiscal 2023 was 17.89M shares, a 27.02% increase from fiscal 2022.
- AGENUS INC weighted average number of shares outstanding, basic for fiscal 2022 was 14.09M shares, a 6053.71% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 41.34M shares 10-Q · filed 2026-08-07 | 39.65M shares 10-Q · filed 2026-08-07 | 37.89M shares derived: average of 3 quarters · filed 2026-08-07 | 36.39M shares derived: average of 4 quarters · filed 2026-08-07 | ||||
| 2026-03-31 | 37.94M shares 10-Q · filed 2026-05-11 | 36.16M shares derived: average of 2 quarters · filed 2026-05-11 | 34.74M shares derived: average of 3 quarters · filed 2026-05-11 | 33.08M shares derived: average of 4 quarters · filed 2026-08-07 | ||||
| 2025-12-31 | 34.38M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | 33.13M shares derived: average of 2 quarters · filed 2026-03-16 | 31.46M shares derived: average of 3 quarters · filed 2026-08-07 | 29.73M shares 10-K · filed 2026-03-16 | ||||
| 2025-09-30 | 31.89M shares 10-Q · filed 2025-11-10 | 30.00M shares derived: average of 2 quarters · filed 2026-08-07 | 28.18M shares 10-Q · filed 2025-11-10 | 26.84M shares derived: average of 4 quarters · filed 2026-08-07 | ||||
| 2025-06-30 | 28.12M shares 10-Q · filed 2026-08-07 | 26.30M shares 10-Q · filed 2026-08-07 | 25.16M shares derived: average of 3 quarters · filed 2026-08-07 | 24.26M shares derived: average of 4 quarters · filed 2026-08-07 | ||||
| 2025-03-31 | 24.47M shares 10-Q · filed 2026-05-11 | 23.69M shares derived: average of 2 quarters · filed 2026-05-11 | 22.98M shares derived: average of 3 quarters · filed 2026-05-11 | 22.50M shares derived: average of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | 22.91M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | 22.23M shares derived: average of 2 quarters · filed 2026-03-16 | 21.84M shares derived: average of 3 quarters · filed 2026-03-16 | 21.47M shares 10-K · filed 2026-03-16 | ||||
| 2024-09-30 | 21.55M shares 10-Q · filed 2025-11-10 | 21.31M shares derived: average of 2 quarters · filed 2025-11-10 | 21.00M shares 10-Q · filed 2025-11-10 | 20.55M shares derived: average of 4 quarters · filed 2026-03-16 | ||||
| 2024-06-30 | 21.06M shares 10-Q · filed 2025-08-11 | 20.71M shares 10-Q · filed 2025-08-11 | 20.21M shares derived: average of 3 quarters · filed 2026-03-16 | 19.89M shares derived: average of 4 quarters · filed 2026-03-16 | ||||
| 2024-03-31 | 20.37M shares 10-Q · filed 2025-05-12 | 19.79M shares derived: average of 2 quarters · filed 2026-03-16 | 19.49M shares derived: average of 3 quarters · filed 2026-03-16 | 19.01M shares derived: average of 4 quarters · filed 2026-03-16 | ||||
| 2023-12-31 | 19.20M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | 19.05M shares derived: average of 2 quarters · filed 2026-03-16 | 18.56M shares derived: average of 3 quarters · filed 2026-03-16 | 17.89M shares 10-K · filed 2026-03-16 | 357.89K shares 10-K · filed 2024-03-14 | |||
| 2023-09-30 | 18.91M shares 10-Q · filed 2024-11-12 | 378.15K shares 10-Q · filed 2023-11-09 | 18.24M shares derived: average of 2 quarters · filed 2024-11-12 | 17.46M shares 10-Q · filed 2024-11-12 | 349.17K shares 10-Q · filed 2023-11-09 | 26.96M shares derived: average of 4 quarters · filed 2025-03-17 | ||
| 2023-06-30 | 17.57M shares 10-Q · filed 2024-08-08 | 351.38K shares 10-Q · filed 2023-08-08 | 16.72M shares 10-Q · filed 2024-08-08 | 334.34K shares 10-Q · filed 2023-08-08 | 29.65M shares derived: average of 3 quarters · filed 2025-03-17 | 22.31M shares derived: average of 4 quarters · filed 2025-03-17 | ||
| 2023-03-31 | 15.86M shares 10-Q · filed 2024-05-07 | 317.11K shares 10-Q · filed 2023-05-09 | 35.69M shares derived: average of 2 quarters · filed 2025-03-17 | 23.89M shares derived: average of 3 quarters · filed 2025-03-17 | 17.99M shares derived: average of 4 quarters · filed 2025-03-17 | |||
| 2022-12-31 | 55.53M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17 | 27.91M shares derived: average of 2 quarters · filed 2025-03-17 | 18.70M shares derived: average of 3 quarters · filed 2025-03-17 | 14.09M shares 10-K · filed 2025-03-17 | 281.74K shares 10-K · filed 2023-03-16 | |||
| 2022-09-30 | 286.85K shares 10-Q · filed 2023-11-09 | 281.94K shares derived: average of 2 quarters · filed 2023-11-09 | 274.17K shares 10-Q · filed 2023-11-09 | 269.71K shares derived: average of 4 quarters · filed 2024-03-14 | ||||
| 2022-06-30 | 277.03K shares 10-Q · filed 2023-08-08 | 267.72K shares 10-Q · filed 2023-08-08 | 264.00K shares derived: average of 3 quarters · filed 2024-03-14 | 256.85K shares derived: average of 4 quarters · filed 2024-03-14 | ||||
| 2022-03-31 | 258.31K shares 10-Q · filed 2023-05-09 | 257.48K shares derived: average of 2 quarters · filed 2024-03-14 | 250.12K shares derived: average of 3 quarters · filed 2024-03-14 | 243.32K shares derived: average of 4 quarters · filed 2024-03-14 | ||||
| 2021-12-31 | 256.64K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | 246.03K shares derived: average of 2 quarters · filed 2024-03-14 | 238.32K shares derived: average of 3 quarters · filed 2024-03-14 | 228.92K shares 10-K · filed 2024-03-14 | ||||
| 2021-09-30 | 235.41K shares 10-Q · filed 2022-11-08 | 229.16K shares derived: average of 2 quarters · filed 2022-11-08 | 219.68K shares 10-Q · filed 2022-11-08 | |||||
| 2021-06-30 | 222.91K shares 10-Q · filed 2022-08-09 | 211.68K shares 10-Q · filed 2022-08-09 | ||||||
| 2020-12-31 | 192.97K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | 187.82K shares derived: average of 2 quarters · filed 2023-03-16 | 172.50K shares 10-K · filed 2023-03-16 | |||||
| 2020-09-30 | 182.67K shares 10-Q · filed 2021-11-09 | 165.68K shares 10-Q · filed 2021-11-09 | ||||||
| 2020-03-31 | 145.06K shares 10-Q · filed 2020-05-11 | |||||||
| 2019-03-31 | 129.70K shares 10-Q · filed 2020-05-11 | |||||||
| 2018-03-31 | 102.58K shares 10-Q · filed 2019-05-10 | |||||||
| 2013-03-31 | 25.07M shares 10-Q · filed 2013-05-10 | |||||||
| 2012-03-31 | 22.34M shares 10-Q · filed 2013-05-10 | |||||||
| 2011-03-31 | 18.81M shares 10-Q · filed 2012-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |